Draftkings Inc. diskutieren
DraftKings (NASDAQ:DKNG) had its "buy" rating reaffirmed by analysts at Stifel Nicolaus. They now have a $46.00 price target on the stock, down previously from $50.00.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at Guggenheim from $55.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at Truist Financial Corporation from $50.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $42.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at Macquarie from $50.00 to $48.00. They now have an "outperform" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at Barclays PLC from $54.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at Citigroup Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target lowered by analysts at Mizuho from $54.00 to $46.00. They now have an "outperform" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $48.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for DKNG provided by MarketBeat
DraftKings (NASDAQ:DKNG) had its price target raised by analysts at BTIG Research from $42.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
Neueste Beiträge
StockNews_com in Karo Pharma AB diskutieren